Recent news of a meningitis B (MenB) outbreak in Kent has understandably caused concern among families, students, and communities across the UK. We have seen this here, in York, with our 2 universities, and several colleges and 6th forms. While cases remain localised in the South East, the situation is a stark reminder of how serious meningococcal disease can be—and how important vaccination and early recognition are.

In this article, we explain what MenB is, who is at risk, the role of vaccination, and the key symptoms you should never ignore—along with an important clarification about the difference between MenB and MenACWY vaccines.

What is Meningitis B?

Meningitis B is caused by the bacterium Neisseria meningitidis (group B), one of the most common causes of bacterial meningitis in the UK. It can lead to:

  • Meningitis (infection of the lining of the brain and spinal cord)
  • Septicaemia (blood poisoning)

The disease can progress rapidly and is potentially life-threatening, even in otherwise healthy individuals.

The Recent Kent Outbreak: What Happened?

In March 2026, an outbreak linked to students in Canterbury led to:

  • Over 29 confirmed and suspected cases (so far)
  • Multiple hospitalisations
  • Tragically, 2 reported deaths among young people (so far)

Public health teams have responded quickly with antibiotics and targeted vaccination in the area of the outbreak and amongst close contacts of those affected. The outbreak has been associated with close-contact environments such as student housing and social venues.

Encouragingly, current evidence suggests that the MenB vaccine is effective against the strain involved.

Who is Eligible for the MenB Vaccine on the NHS?

Meningitis B vaccination has been part of the routine infant programme since 2015

  • It is given at:
    • 8 weeks
    • 12 weeks
    • Booster at 1 year

👉 This means most teenagers and young adults today were not routinely vaccinated against MenB.

Most, though, can still receive the vaccine privately, subject to availability.

Why Are Teenagers and Students at Higher Risk?

Guidance from the Oxford Vaccine Knowledge Project highlights that:

  • Meningococcal bacteria spread through close contact (coughing, sneezing, kissing, sharing drinks or vapes etc.)
  • Many people carry the bacteria without symptoms
  • Teenagers and young adults have higher carriage rates

University settings increase risk due to:

  • Shared accommodation
  • Social mixing
  • Close-contact behaviours (e.g. sharing drinks, kissing)

MenB vs MenACWY: What’s the Difference?

This is one of the most common and important questions we’re being asked at the moment.

MenB Vaccine

  • Protects against meningococcal group B
  • Part of routine infant NHS schedule (since 2015)
  • Not routinely offered to teenagers on the NHS
  • Available privately at some pharmacies, including Monkbar Pharmacy (subject to stock)

MenACWY Vaccine

  • Protects against groups A, C, W and Y
  • Offered free on the NHS to teenagers, typically:
    • Around age 13–14 (around Yr 9 in the school programme)
    • Catch-up for university entrants (up to the age of 25yrs)
  • Can be a requirement for some foreign trips and recommended for others
  • At the current time, Men ACWY vaccine supplies remain good and this vaccine is also offered privately at Monkbar Pharmacy

Key Point:

👉 MenACWY does NOT protect against MenB

This is particularly important in the current outbreak, as:

  • Many students have had MenACWY vaccine
  • But remain unprotected against Meningitis B infection unless they have been vaccinated separately.

Vaccine Demand and Supply Challenges

Following the Kent outbreak, demand for MenB vaccination has surged:

  • Pharmacies, like Monkbar Pharmacy, have experienced a sharp increase in enquiries
  • UK suppliers have experienced temporary stock shortages, as the initial national response was to quarantine vaccine stocks whilst assessing the ongoing situation in the outbreak area(s)
  • On 19th March the UKHSA announced the release of 20,000 doses of Men B vaccine to UK pharmacies. This only equals around 2 vaccines per pharmacy so demand is still outweighing supply.
  • At Monkbar Pharmacy we always put a great deal of effort into obtaining supplies of difficult to source medicines and vaccines. Since the start of the outbreak, we have managed to get a small number of doses in stock. These were issued to some people on our wait list.
  • If you would like to join our wait list for Men B vaccination, please email contact@monkbarpharmacy.co.uk

We are actively monitoring stock availability and will update patients as and when we get supplies.

Signs and Symptoms: When to Seek Urgent Help

Meningitis.org is a great website to refer to for symptoms. These can develop quickly and may initially resemble flu, or even a hangover.

Early symptoms:

  • Fever
  • Headache
  • Vomiting
  • Muscle aches


More serious symptoms:

  • Stiff neck
  • Sensitivity to light
  • Confusion or drowsiness
  • Seizures


Emergency warning signs:

  • Non-blanching rash (does not fade when pressed)
  • Cold hands and feet
  • Limb pain
  • Pale or mottled skin

⚠️ Symptoms can appear in any order—and not everyone gets a rash.

👉 Always seek urgent medical attention if concerned.

Why Vaccination Still Matters

The UK “Green Book” highlights that MenB vaccination:

  • Provides direct protection against invasive disease
  • Is particularly valuable in outbreak situations
  • Helps reduce severity and complications compared to those who are NOT vaccinated

Even though it is not routinely offered to older age groups on the NHS, it remains an important option—especially during periods of increased risk.

What Should You Do Now?

  • ✅ Check vaccination history (especially for teenagers and students). This is often available through the NHS App.
  • ✅ Understand that MenACWY vaccination does NOT give MenB protection
  • ✅ Consider private MenB vaccination where appropriate and available
  • ✅ Stay alert to symptoms that may suggest infection
  • ✅ Seek urgent help if symptoms develop

Final Thoughts

It’s important to know that Meningitis B is NOT commonly a risk for most people due to low circulating levels usually. In addition, the bacteria that cause Meningitis spread LESS easily than the viruses that lead to the flu, COVID or measles.

The Kent outbreak, though, is a reminder that meningitis, whilst rare, can be fast-moving and devastating. Understanding the difference between vaccines, recognising symptoms early, and acting quickly can save lives.

If you have questions about MenB vaccination or current availability, keep an eye on our website and social media for updates.

This blog is for informational purposes only and does not replace professional medical advice. Always consult a healthcare professional if you are concerned about symptoms or vaccination suitability.